Apyx Medical (APYX) Cash from Operations (2011 - 2026)

Apyx Medical has reported Cash from Operations for 16 years, with the latest figure at 572000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 18.52% year-over-year to 572000.0; the trailing twelve-month figure through Mar 2026 stood at 7870000.0 (up 36.57% YoY), and the FY2025 full-year result was 8000000.0, up 55.67% from the prior year.
• Cash from Operations for Q1 2026 stood at 572000.0, up from 2529000.0 in the prior quarter.
• The five-year high for Cash from Operations was 3696000.0 in Q3 2023, with the low at 6341000.0 in Q1 2024.
• Historically, Cash from Operations has averaged 3067529.41 across 5 years, with a median of 3536000.0 in 2025.
• Annual changes were most pronounced in 2022 — Cash from Operations plunged 2216.82% — and 2023, when it jumped 168.96%.
• Apyx Medical's Cash from Operations stood at 4530000.0 in 2022, then jumped by 51.17% to 2212000.0 in 2023, then slumped by 32.78% to 2937000.0 in 2024, then advanced by 13.89% to 2529000.0 in 2025, then surged by 77.38% to 572000.0 in 2026.
• The last three Cash from Operations figures came in at 572000.0 (Q1 2026), 2529000.0 (Q4 2025), and 3536000.0 (Q3 2025), per Business Quant data.